Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Silent, invisible and unacknowledged: experiences of young caregivers of single parents diagnosed with multiple sclerosis.
Multiple sclerosis: Daclizumab HYP shows efficacy in patients with relapsing-remitting MS.
Transient oscillatory dynamics of interferon beta signaling in macrophages.
Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Assessment of upper limb motor function in patients with multiple sclerosis using the Virtual Peg Insertion Test: A pilot study.
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
Recent onset disequilibrium mimicking acute vestibulopathy in early multiple sclerosis.
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis.
Latency of multifocal Visual Evoked Potentials in non-optic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
Pain and Cognition in Multiple Sclerosis.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
Serum proteomics in multiple sclerosis disease progression.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Pages
« first
‹ previous
…
552
553
554
555
556
557
558
559
560
…
next ›
last »